SUBSCRIBE
SUBSCRIBE

Texas

LATEST FROM BIOSPACE
Lone Star Bio
Having Babies Sit Up May Help Them Learn, North Dakota State University Study
December 18, 2012
 · 
1 min read
Lone Star Bio
Light Used to Remotely Trigger Biochemical Reactions, Rice University Study
December 14, 2012
 · 
1 min read
Lone Star Bio
Biocompatible Patch Heals Infants With Birth Defects, Rice University and Texas Children’s Hospital Study
December 13, 2012
 · 
1 min read
Lone Star Bio
Zapped By Laser, Nanobubbles Kill Cancer, Rice University Study
December 11, 2012
 · 
1 min read
Lone Star Bio
One Gene Predicts Rapid ALS Progression 80 Percent of the Time, Methodist Neurological Institute Study
December 10, 2012
 · 
1 min read
Lone Star Bio
Improving the Outcome for Patients With Diseases Whose Treatment Requires Ex Vivo Cell Processing, Rice University Study
December 6, 2012
 · 
1 min read
Lone Star Bio
World’s Smallest Wrench Puts a New Twist on Microscopic Manipulation, University of Texas Study
December 4, 2012
 · 
1 min read
Lone Star Bio
Metabolic Protein Launches Sugar Feast That Nurtures Brain Tumors, University of Texas MD Anderson Cancer Center Study
November 27, 2012
 · 
1 min read
Lone Star Bio
Diabetes Drug Improves Memory, University of Texas Medical Branch Study
November 21, 2012
 · 
1 min read
Lone Star Bio
Are Knee Injuries Tied to Menstrual Cycle? University of Texas Study
November 16, 2012
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
Triumvira Immunologics’ Late-Breaking Abstract Selected for Oral Presentation at the 39th SITC Annual Meeting Demonstrates Preliminary Safety and Promising Clinical Activity of TAC01-CLDN18.2 Cell Therapy in Patients with Solid Tumors
November 12, 2024
 · 
4 min read
Press Releases
Autonomix Medical, Inc. Reports Second Quarter Fiscal Year 2025 Financial Results and Provides a Corporate Update
November 11, 2024
 · 
6 min read
Press Releases
Medicenna Announces Positive Single-Agent Activity of MDNA11 from Dose Expansion Cohort and Encouraging Safety Profile in Combination with KEYTRUDA® (pembrolizumab) at the 39th Annual Meeting of SITC
November 11, 2024
 · 
10 min read
Press Releases
Bio-Path Holdings to Announce Third Quarter 2024 Financial Results on November 15, 2024
November 11, 2024
 · 
1 min read
Press Releases
Conflixis Raises $4.2 Million in Seed Funding to Transform Conflicts of Interest (COI) Management in Healthcare
November 11, 2024
 · 
3 min read
Press Releases
Immatics Announces Multiple Presentations at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) on TCR-T Therapy Candidates Targeting PRAME
November 11, 2024
 · 
12 min read
Press Releases
A2 Bio Highlights Progress of Tmod™ CAR T-Cell Clinical Programs During 2024 Annual Meeting of the Society for Immunotherapy of Cancer
November 11, 2024
 · 
9 min read
Press Releases
Medicenna Presents Preclinical Data from its Anti-PD1-IL-2 BiSKIT and IL-2 Super Agonist Programs at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
November 8, 2024
 · 
8 min read
Press Releases
Io Therapeutics, Inc., announces presentation of data on its RAR gamma agonist compound IRX5010 demonstrating inhibition of tumor infiltrating myeloid derived suppressor cells, promotion of tumor infiltrating T-cells, and effective tumor growth inhibition in murine models of breast, colorectal, and prostate cancers
November 8, 2024
 · 
3 min read
Press Releases
Natera to Participate in Upcoming Investor Conferences
November 8, 2024
 · 
1 min read
Load More